A disposable aerosol generator for use with an inhaler device, which includes a heater adapted to volatilize liquid stored in the disposable aerosol generator and a method of using the inhaler, is provided. The disposable body includes a sealed chamber and an openable outlet. The chamber is located between first and second layers of material. The chamber holds liquid, which is expelled through the opened outlet when the fluid in the chamber is volatilized by the heater. The disposable body can include a series of spaced apart aerosol generators, each of which can be advanced to a release position at which the heater can heat one of the fluid containing chambers. Prior to heating the liquid, the outlet can be opened and the volatilized fluid can be expelled from the opened outlet into a passage of a dispensing member.
RELATED PATENT APPLICATIONS
This application is a continuation application of U.S. application Ser. No. 10/005,155 entitled DISPOSABLE INHALER SYSTEM, filed on Dec. 7, 2001, which is a continuation-in-part of U.S. application Ser. No. 09/742,321, filed on Dec. 22, 2000, now U.S. Pat. No. 6,799,572, the entire content of which is hereby incorporated by reference.
A liquid aerosol formulation comprising at least one thermally stable active ingredient selected from the group consisting of butalbital, lorazepam, ipratropium, baclofen, morphine, scopolamine, pharmaceutically acceptable salts and esters thereof and derivatives thereof. The liquid formulation can include an organic solvent such as propylene glycol and one or more optional excipients. The active ingredient can be present in an amount of 0.01 to 5 weight percent and the formulation can be heated to provide a vapor which forms an aerosol having a mass median aerodynamic diameter of less than 3 .mu.m.
A liquid aerosol formulation comprising at least one thermally stable active ingredient selected from the group consisting of buspirone, buprenorphine, triazolam, cyclobenzaprine, zolpidem, pharmaceutically acceptable salts and esters thereof and derivatives thereof. The liquid formulation can include an organic solvent such as propylene glycol and one or more optional excipients. The active ingredient can be present in an amount of 0.01 to 5 wt. % and the formulation can be heated to provide a vapor which forms an aerosol having a mass median aerodynamic diameter of less than 3 .mu.m.
